Voltaren emulgel 2% gel - for muscle and joint pain 100 gr
Estimated delivery: 1-3 business days
Estimated delivery: 1-3 business days
Information on returns and shipments
Payment methods
Medicated plasters for inflammation.
Fastuflex for the local symptomatic treatment of rheumatic or traumatic pain and inflammation of joints, muscles, tendons and ligaments.
Active ingredients - Each 10 cm x 14 cm medicated plaster contains a total of 180 mg of diclofenac epolamine, equivalent to 140 mg of diclofenac sodium. Excipients with known effect: methyl parahydroxybenzoate (E218): 14 mg propyl parahydroxybenzoate (E216): 7 mg propylene glycol: 420 mg The quantities indicated refer to a single plaster. For the full list of excipients, see section 6.1.
Excipients - Backing layer: non-woven polyester backing. Adhesive layer (active gel): gelatin, povidone (K90), liquid sorbitol (non-crystallizing), heavy kaolin, titanium dioxide (E171), propylene glycol, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), disodium edetate, tartaric acid, aluminum glycinate, sodium carmellose, sodium polyacrylate, 1,3-butylene glycol, polysorbate 80, purified water. Protective layer: polypropylene film.
For cutaneous use only. Dosage One (1) patch on the most painful area once or twice a day. Duration of treatment: Fastuflex should be used for the shortest possible time. The maximum duration of treatment is 14 consecutive days. Elderly: This medicine should be used with caution in elderly patients, as they are more susceptible to side effects. Children and adolescents under 16 years: There are insufficient data on efficacy and safety in children and adolescents under 16 years. In adolescents aged 16 years and over, if this product is needed for more than 7 days for pain relief or in case of worsening symptoms, the patient/parents of the adolescent are advised to consult a doctor. Method of administration: Cut the sachet containing the medicated plaster as indicated. Take a medicated plaster, remove the plastic film used to protect the adhesive surface and apply it to the painful joint or body area. If necessary, the plaster can be held in place with an elastic net. Carefully reseal the pouch with the sliding seal. The patch must be used whole.
The medicated plaster should be applied only to intact, healthy skin and not to broken skin or open wounds, and should not be worn while bathing or showering. The medicated plaster should not come into contact with or be applied to mucous membranes or eyes. It should not be used with occlusive dressings. Discontinue treatment immediately if a skin rash develops following application of the medicated plaster. Do not administer any medicinal products containing diclofenac or other NSAIDs at the same time, either topically or systemically. The possibility of systemic adverse events resulting from the application of topical diclofenac cannot be ruled out if the preparation is used for a prolonged period of time (see the product information for systemic forms of diclofenac). Although the expected systemic effects are limited, the patch should be used with caution in patients with renal, cardiac, or hepatic impairment, a history of peptic ulcer or inflammatory bowel disease, or a bleeding diathesis. Nonsteroidal anti-inflammatory drugs should be used with particular caution in elderly patients, as they are more susceptible to adverse effects. This medicine contains methyl parahydroxybenzoate and propyl parahydroxybenzoate. They may cause allergic reactions (possibly delayed). It also contains propylene glycol, which may cause skin irritation. Patients should be advised to avoid exposure to direct sunlight and tanning lamps to reduce the risk of photosensitivity. Bronchospasm may occur in patients who currently suffer from, or have suffered from, bronchial asthma, allergic diseases, or an allergy to acetylsalicylic acid or other NSAIDs. The medicated plaster should be used with caution in patients with or without chronic asthma in whom acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs may trigger asthma attacks, urticaria, or acute rhinitis. To minimize the possibility of adverse effects, it is recommended to use the lowest effective dose for the shortest duration necessary to control symptoms, without exceeding the approved maximum limit of 14 days.
10 medicated plasters of 180 mg.
This product has been on sale since 27/12/2019
In the last 30 days, the product's lowest price was 14,89 €